TY - STD TI - UNAIDS. Fact sheet November 2016. http://www.unaids.org/en/resources/fact-sheet. Accessed 3 Dec 2016. UR - http://www.unaids.org/en/resources/fact-sheet ID - ref1 ER - TY - STD TI - UNAIDS. The HIV and AIDS Uganda Country Progress Report 2014. http://www.unaids.org/sites/default/files/country/documents/UGA_narrative_report_2015.pdf. Accessed 6 Oct 2015. UR - http://www.unaids.org/sites/default/files/country/documents/UGA_narrative_report_2015.pdf ID - ref2 ER - TY - JOUR AU - Maher, D. AU - Waswa, L. AU - Baisley, K. AU - Karabarinde, A. AU - Unwin, N. PY - 2011 DA - 2011// TI - Epidemiology of hypertension in low-income countries: a cross-sectional population-based survey in rural Uganda JO - J Hypertens VL - 29 UR - https://doi.org/10.1097/HJH.0b013e3283466e90 DO - 10.1097/HJH.0b013e3283466e90 ID - Maher2011 ER - TY - JOUR AU - Bimenya, G. AU - Okot, J. AU - Nangosa, H. AU - Anguma, S. AU - Byarugaba, W. PY - 2006 DA - 2006// TI - Plasma cholesterol and related lipid levels of seemingly healthy public service employees in Kampala, Uganda JO - Afr Health Sci. VL - 6 ID - Bimenya2006 ER - TY - JOUR AU - Haugaard, S. B. PY - 2006 DA - 2006// TI - Toxic metabolic syndrome associated with HAART JO - Expert Opin Drug Metab Toxicol. VL - 2 UR - https://doi.org/10.1517/17425255.2.3.429 DO - 10.1517/17425255.2.3.429 ID - Haugaard2006 ER - TY - JOUR AU - Hofman, P. AU - Nelson, A. M. PY - 2006 DA - 2006// TI - The pathology induced by highly active antiretroviral therapy against human immunodeficiency virus: an update JO - Curr Med Chem VL - 13 UR - https://doi.org/10.2174/092986706778742891 DO - 10.2174/092986706778742891 ID - Hofman2006 ER - TY - JOUR AU - Bradbury, R. A. AU - Samaras, K. PY - 2008 DA - 2008// TI - Antiretroviral therapy and the human immunodeficiency virus—improved survival but at what cost? JO - Diabetes Obes Metab VL - 10 UR - https://doi.org/10.1111/j.1463-1326.2007.00760.x DO - 10.1111/j.1463-1326.2007.00760.x ID - Bradbury2008 ER - TY - JOUR AU - Montessori, V. AU - Press, N. AU - Harris, M. AU - Akagi, L. AU - Montaner, J. S. PY - 2004 DA - 2004// TI - Adverse effects of antiretroviral therapy for HIV infection JO - CMAJ VL - 170 ID - Montessori2004 ER - TY - JOUR AU - Herman, J. S. AU - Easterbrook, P. J. PY - 2001 DA - 2001// TI - PJ E. The metabolic toxicities of antiretroviral therapy JO - Int J STD AIDS VL - 12 UR - https://doi.org/10.1258/0956462011923714 DO - 10.1258/0956462011923714 ID - Herman2001 ER - TY - JOUR AU - Post, F. A. AU - Holt, S. G. PY - 2009 DA - 2009// TI - SG H. Recent developments in HIV and the kidney JO - Curr Opin Infect Dis. VL - 22 UR - https://doi.org/10.1097/QCO.0b013e328320ffec DO - 10.1097/QCO.0b013e328320ffec ID - Post2009 ER - TY - JOUR AU - Roling, J. AU - Schmid, H. AU - Fischereder, M. AU - Draenert, R. AU - Goebel, F. D. PY - 2006 DA - 2006// TI - HIV-associated renal diseases and highly active antiretroviral therapy-induced nephropathy JO - Clin Infect Dis VL - 42 UR - https://doi.org/10.1086/503566 DO - 10.1086/503566 ID - Roling2006 ER - TY - STD TI - WHO. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Geneva: World Health Organization; 2013. http://www.who.int/hiv/pub/guidelines/arv2013. Accessed 26 Jan 2016. UR - http://www.who.int/hiv/pub/guidelines/arv2013 ID - ref12 ER - TY - STD TI - Ministry of Health U. Addendum to the National Antiretroviral Treatment Guidelines. 2013. http://preventcrypto.org/wp-content/uploads/2012/07/Uganda-National-ART-Guidelines_2014.pdf. Accessed 15 Jan 2015. UR - http://preventcrypto.org/wp-content/uploads/2012/07/Uganda-National-ART-Guidelines_2014.pdf ID - ref13 ER - TY - STD TI - Ministry of Health, Republic of Kenya, (NASCOP). NAaSCP: guidelines on use of antiretroviral drugs for treating and preventing HIV infection: a rapid advice. 2014. http://guidelines.health.go.ke:8000/media/Rapid_Advice_Booklet_2014_July_V5.pdf. Accessed 17 Feb 2016. UR - http://guidelines.health.go.ke:8000/media/Rapid_Advice_Booklet_2014_July_V5.pdf ID - ref14 ER - TY - STD TI - Ministry of Health and Social Welfare, Tanzania TURo. NACProgramme: the United Republic of Tanzania. National Guidelines for the Management of HIV and AIDS. Fifth Edition-May, 2015. http://www.nacp.go.tz/site/publications/care-and-treatment/NationalGuidelineforManagementHIV.pdf. Accessed 15 Feb 2016. UR - http://www.nacp.go.tz/site/publications/care-and-treatment/NationalGuidelineforManagementHIV.pdf ID - ref15 ER - TY - JOUR AU - Jülg, B. D. AU - Bogner, J. R. AU - Crispin, A. AU - Goebel, F. D. PY - 2005 DA - 2005// TI - Progression of renal impairment under therapy with tenofovir JO - AIDS. VL - 19 UR - https://doi.org/10.1097/01.aids.0000180109.03759.35 DO - 10.1097/01.aids.0000180109.03759.35 ID - Jülg2005 ER - TY - JOUR AU - Zimmermann, A. E. AU - Pizzoferrato, T. AU - Bedford, J. AU - Morris, A. AU - Hoffman, R. AU - Braden, G. PY - 2006 DA - 2006// TI - Tenofovir-associated acute and chronic kidney disease: a case of multiple drug interactions JO - Clin Infect Dis VL - 42 UR - https://doi.org/10.1086/499048 DO - 10.1086/499048 ID - Zimmermann2006 ER - TY - JOUR AU - Gallant, J. E. AU - Winston, J. A. AU - DeJesus, E. AU - Pozniak, A. L. AU - Chen, S. -. S. AU - Cheng, A. K. PY - 2008 DA - 2008// TI - The 3-year renal safety of a tenofovir disoproxil fumarate vs. a thymidine analogue-containing regimen in antiretroviral-naive patients JO - AIDS. VL - 22 UR - https://doi.org/10.1097/QAD.0b013e3283112b8e DO - 10.1097/QAD.0b013e3283112b8e ID - Gallant2008 ER - TY - JOUR AU - Ryom, L. AU - Mocroft, A. AU - Kirk, O. AU - Worm, S. W. AU - Kamara, D. A. AU - Reiss, P. PY - 2013 DA - 2013// TI - Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: the D: A: D Study JO - J Infect Dis VL - 207 UR - https://doi.org/10.1093/infdis/jit043 DO - 10.1093/infdis/jit043 ID - Ryom2013 ER - TY - JOUR AU - Labarga, P. AU - Barreiro, P. AU - Martin-Carbonero, L. AU - Rodriguez-Novoa, S. AU - Solera, C. AU - Medrano, J. PY - 2009 DA - 2009// TI - Kidney tubular abnormalities in the absence of impaired glomerular function in HIV patients treated with tenofovir JO - AIDS. VL - 23 UR - https://doi.org/10.1097/QAD.0b013e3283262a64 DO - 10.1097/QAD.0b013e3283262a64 ID - Labarga2009 ER - TY - JOUR AU - Laprise, C. AU - Baril, J. -. G. AU - Dufresne, S. AU - Trottier, H. PY - 2012 DA - 2012// TI - Association between tenofovir exposure and reduced kidney function in a cohort of HIV-positive patients: results from 10 years of follow-up JO - Clin Infect Dis VL - 56 UR - https://doi.org/10.1093/cid/cis937 DO - 10.1093/cid/cis937 ID - Laprise2012 ER - TY - JOUR AU - Oboho, I. AU - Abraham, A. AU - Benning, L. AU - Anastos, K. AU - Sharma, A. AU - Young, M. PY - 2013 DA - 2013// TI - Tenofovir use and urinary biomarkers among HIV-infected women in the Women’s Interagency HIV Study (WIHS) JO - J Acquir Immune Defic Syndr VL - 62 UR - https://doi.org/10.1097/QAI.0b013e31828175c9 DO - 10.1097/QAI.0b013e31828175c9 ID - Oboho2013 ER - TY - JOUR AU - Gupta, S. K. PY - 2008 DA - 2008// TI - Tenofovir-associated Fanconi syndrome: review of the FDA adverse event reporting system JO - AIDS Patient Care STDS. VL - 22 UR - https://doi.org/10.1089/apc.2007.0052 DO - 10.1089/apc.2007.0052 ID - Gupta2008 ER - TY - JOUR AU - Cm, W. PY - 2008 DA - 2008// TI - HIV and the kidney: a spotlight on racial disparities JO - J Infect Dis VL - 197 UR - https://doi.org/10.1086/587995 DO - 10.1086/587995 ID - Cm2008 ER - TY - JOUR AU - Mugyenyi, P. AU - Walker, A. S. AU - Hakim, J. AU - Munderi, P. AU - Gibb, D. M. AU - Kityo, C. PY - 2010 DA - 2010// TI - Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial JO - Lancet VL - 375 UR - https://doi.org/10.1016/S0140-6736(09)62067-5 DO - 10.1016/S0140-6736(09)62067-5 ID - Mugyenyi2010 ER - TY - JOUR AU - Morgan, D. AU - Malamba, S. S. AU - Maude, G. H. AU - Okongo, M. J. AU - Wagner, H. U. AU - Mulder, D. W. PY - 1997 DA - 1997// TI - An HIV-1 natural history cohort and survival times in rural Uganda JO - AIDS. VL - 11 UR - https://doi.org/10.1097/00002030-199705000-00011 DO - 10.1097/00002030-199705000-00011 ID - Morgan1997 ER - TY - JOUR AU - Shafer, L. A. AU - Nsubuga, R. N. AU - White, R. AU - Mayanja, B. N. AU - Chapman, R. AU - O’Brien, K. PY - 2011 DA - 2011// TI - Antiretroviral therapy and sexual behavior in Uganda: a cohort study JO - AIDS. VL - 25 UR - https://doi.org/10.1097/QAD.0b013e328341fb18 DO - 10.1097/QAD.0b013e328341fb18 ID - Shafer2011 ER - TY - JOUR AU - Mayanja, B. N. AU - Todd, J. AU - Hughes, P. AU - Paal, L. AU - Mugisha, J. O. AU - Atuhumuza, E. PY - 2010 DA - 2010// TI - Septicaemia in a population-based HIV clinical cohort in rural Uganda, 1996–2007: incidence, aetiology, antimicrobial drug resistance and impact of antiretroviral therapy JO - Trop Med Int Health Trop Med Int Health. VL - 15 UR - https://doi.org/10.1111/j.1365-3156.2010.02528.x DO - 10.1111/j.1365-3156.2010.02528.x ID - Mayanja2010 ER - TY - JOUR AU - Iwuji, C. C. AU - Mayanja, B. N. AU - Weiss, H. A. AU - Atuhumuza, E. AU - Hughes, P. AU - Maher, D. PY - 2011 DA - 2011// TI - Morbidity in HIV-1-infected individuals before and after the introduction of antiretroviral therapy: a longitudinal study of a population-based cohort in Uganda JO - HIV Med. VL - 12 UR - https://doi.org/10.1111/j.1468-1293.2011.00923.x DO - 10.1111/j.1468-1293.2011.00923.x ID - Iwuji2011 ER - TY - JOUR AU - Mayanja, B. N. AU - Baisley, K. AU - Nalweyiso, N. AU - Kibengo, F. M. AU - Mugisha, J. O. AU - Paal, L. PY - 2011 DA - 2011// TI - Using verbal autopsy to assess the prevalence of HIV infection among deaths in the ART period in rural Uganda: a prospective cohort study, 2006–2008 JO - Popul Health Metr. VL - 9 UR - https://doi.org/10.1186/1478-7954-9-36 DO - 10.1186/1478-7954-9-36 ID - Mayanja2011 ER - TY - JOUR AU - Asiki, G. AU - Murphy, G. AU - Nakiyingi-Miiro, J. AU - Seeley, J. AU - Nsubuga, R. N. AU - Karabarinde, A. PY - 2013 DA - 2013// TI - The general population cohort in rural south-western Uganda: a platform for communicable and non-communicable disease studies JO - Int J Epidemiol VL - 42 UR - https://doi.org/10.1093/ije/dys234 DO - 10.1093/ije/dys234 ID - Asiki2013 ER - TY - JOUR AU - French, N. AU - Nakiyingi, J. AU - Carpenter, L. AU - Lugada, E. AU - Watera, C. AU - Moi, K. PY - 2000 DA - 2000// TI - 23–valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: double-blind, randomised and placebo controlled trial JO - Lancet VL - 355 UR - https://doi.org/10.1016/S0140-6736(00)02377-1 DO - 10.1016/S0140-6736(00)02377-1 ID - French2000 ER - TY - STD TI - Ministry of Health, Uganda. Integrated national guidelines on antiretroviral therapy, prevention of mother to child transmission of HIV and on infant & young child feeding. First Edition, June 2011. http://www.emtct-iatt.org/wp-content/uploads/2014/05/GL_Integrated-National-Guidelines-on-ART-PMTCT-and-IYCF-June-2011-MOH-Uganda_0.pdf. Accessed 27 Sept 2015. UR - http://www.emtct-iatt.org/wp-content/uploads/2014/05/GL_Integrated-National-Guidelines-on-ART-PMTCT-and-IYCF-June-2011-MOH-Uganda_0.pdf ID - ref33 ER - TY - JOUR AU - Asiki, G. AU - Murphy, G. A. AU - Baisley, K. AU - Nsubuga, R. N. AU - Karabarinde, A. AU - Newton, R. PY - 2015 DA - 2015// TI - Prevalence of dyslipidaemia and associated risk factors in a rural population in South-Western Uganda: a community based survey JO - PLoS ONE VL - 10 UR - https://doi.org/10.1371/journal.pone.0126166 DO - 10.1371/journal.pone.0126166 ID - Asiki2015 ER - TY - STD TI - WHO. Chronic diseases and health promotion, STEPwise approach to chronic disease risk factor surveillance. http://www.who.int/chp/steps/nauru/en/. Accessed 23 Sept 2015. UR - http://www.who.int/chp/steps/nauru/en/ ID - ref35 ER - TY - JOUR AU - Bennett, D. E. AU - Camacho, R. J. AU - Otelea, D. AU - Kuritzkes, D. R. AU - Fleury, H. AU - Kiuchi, M. PY - 2009 DA - 2009// TI - Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update JO - PLoS ONE VL - 4 UR - https://doi.org/10.1371/journal.pone.0004724 DO - 10.1371/journal.pone.0004724 ID - Bennett2009 ER - TY - JOUR AU - Gifford, R. J. AU - Liu, T. F. AU - Rhee, S. Y. AU - Kiuchi, M. AU - Hue, S. AU - Pillay, D. PY - 2009 DA - 2009// TI - The calibrated population resistance tool: standardized genotypic estimation of transmitted HIV-1 drug resistance JO - Bioinformatics VL - 25 UR - https://doi.org/10.1093/bioinformatics/btp134 DO - 10.1093/bioinformatics/btp134 ID - Gifford2009 ER - TY - JOUR AU - Izzedine, H. AU - Isnard-Bagnis, C. AU - Hulot, J. -. S. AU - Vittecoq, D. AU - Cheng, A. AU - Jais, C. K. PY - 2004 DA - 2004// TI - Renal safety of tenofovir in HIV treatment-experienced patients JO - AIDS. VL - 18 UR - https://doi.org/10.1097/00002030-200404300-00019 DO - 10.1097/00002030-200404300-00019 ID - Izzedine2004 ER - TY - JOUR AU - Kyaw, N. T. T. AU - Harries, A. D. AU - Chinnakali, P. AU - Antierens, A. AU - Soe, K. P. AU - Woodman, M. PY - 2015 DA - 2015// TI - Low incidence of renal dysfunction among HIV-infected patients on a Tenofovir-based first line antiretroviral treatment regimen in Myanmar JO - PLoS ONE VL - 10 UR - https://doi.org/10.1371/journal.pone.0135188 DO - 10.1371/journal.pone.0135188 ID - Kyaw2015 ER - TY - JOUR AU - Nelson, M. R. AU - Katlama, C. AU - Montaner, J. S. AU - Cooper, D. A. AU - Gazzard, B. AU - Clotet, B. PY - 2007 DA - 2007// TI - The safety of tenofovir disoproxil fumarate for the treatment of HIV infection in adults: the first 4 years JO - AIDS. VL - 21 UR - https://doi.org/10.1097/QAD.0b013e3280b07b33 DO - 10.1097/QAD.0b013e3280b07b33 ID - Nelson2007 ER - TY - JOUR AU - Madeddu, G. AU - Bonfanti, P. AU - Giuseppe, V. AU - Carradori, S. AU - Grosso, C. AU - Marconi, P. PY - 2008 DA - 2008// TI - Tenofovir renal safety in HIV-infected patients: results from the SCOLTA project JO - Biomed Pharmacother VL - 62 UR - https://doi.org/10.1016/j.biopha.2007.04.008 DO - 10.1016/j.biopha.2007.04.008 ID - Madeddu2008 ER - TY - JOUR AU - O’Reilly, J. I. AU - Ocama, P. AU - Opio, C. K. AU - Alfred, A. AU - Paintsil, E. AU - Seremba, E. PY - 2011 DA - 2011// TI - Risk factors and seroprevalence of hepatitis C among patients hospitalized at Mulago Hospital, Uganda JO - J Trop Med. VL - 2011 ID - O’Reilly2011 ER - TY - JOUR AU - Walusansa, V. AU - Kagimu, M. PY - 2009 DA - 2009// TI - Screening for hepatitis C among HIV positive patients at Mulago hospital in Uganda JO - Afr Health Sci. VL - 9 ID - Walusansa2009 ER -